CLINICAL OUTCOMES AND BIOMARKER NORMALISATION RESPONSE AT WEEK 16 IN PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO PRIOR BIOLOGICS IN THE POWER TRIAL

Stefan Schreiber  1     Scott Lee  2     C. Janneke van der Woude  3     Ignacio Marín-Jiménez  4     Doug Wolf  5     Elisabeth Schnoy  6     Bruce Salzberg  7     Christopher Busse  8     Maciek Nazar  9     Wayne Langholff  10     Chris Gasink  10     Thomas Baker  10     Bridget Godwin  10     Brian G. Feagan  11    
1 Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany
2 University of Washington, Seattle, United States
3 Erasmus University Medical Center, Rotterdam, Netherlands
4 Hospital Universitario Gregorio Marañón, IiSGM, Madrid, Spain
5 Atlanta Gastroenterology Associates, Atlanta, United States
6 University Hospital of Augsburg, Augsburg, Germany
7 IBD Center of Atlanta, Atlanta, United States
8 Janssen Scientific Affairs, LLC, Horsham, United States
9 Janssen-Cilag Polska Sp. z o.o., Warsaw, Poland
10 Janssen Research & Development, LLC, Spring House, United States
11 University of Western Ontario, London, Canada

Topic
Endoscopy, Gut Microbiota, IBD

Conference
UEG Week Copenhagen 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing